Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial
CONCLUSION: To investigate de-escalation adjuvant treatment for elderly breast cancer patients, we have defined a road map for testing more convenient strategies. This EPOPE phase 3 randomized trial is supported by the GEC-ESTRO breast cancer working group.PMID:33997321 | PMC:PMC8102143 | DOI:10.1016/j.ctro.2021.04.005
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Jean-Michel Hannoun-Levi Emmanuel Chamorey Rabia Boulahssass Csaba Polgar Vratislav Strnad Breast Cancer Working Group of the GEC-ESTRO Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | International Medicine & Public Health | Radiation Therapy | Toxicology | Women